- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03060980
Comparison of Efficacy, Safety, and Tolerability of ITCA 650 to Empagliflozin and Glimepiride as add-on Metformin
March 4, 2019 updated by: Intarcia Therapeutics
A Phase 3b, Randomized, Active Comparator, Open-label, Multicenter Study to Compare the Efficacy, Safety, and Tolerability of ITCA 650 to Empagliflozin and to Glimepiride as Add-on Therapy to Metformin in Patients With Type 2 Diabetes
A Phase 3b, open-label, randomized, multicenter, efficacy, safety, and tolerability study of ITCA 650 compared to Empagliflozin and to Glimepiride, as add-on therapy to Metformin in patients with Type 2 diabetes.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
245
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alberta
-
Red Deer, Alberta, Canada, T466V7
- Bailey Clinic
-
-
British Columbia
-
Victoria, British Columbia, Canada, V8V 4A1
- CookMed Research
-
-
Ontario
-
London, Ontario, Canada, N5W 6A2
- Milestone Research
-
Sarnia, Ontario, Canada, N7T 4X3
- Bluewater Clinical Research Group
-
Toronto, Ontario, Canada, M9V 4B4
- Dr. Anil K. Gupta Medicine Professional Corporation
-
-
-
-
Arizona
-
Fountain Hills, Arizona, United States, 85268
- Fountain Hills Family Practice, P.C.
-
Glendale, Arizona, United States, 85308
- Thomas C. Lenzmeier, M.D., P.C.
-
Phoenix, Arizona, United States, 85018
- Family Practice Specialists
-
Phoenix, Arizona, United States, 85020
- Central Phoenix Medical Center
-
Tempe, Arizona, United States, 85283
- Fiel Family and Sports Medicine
-
Tucson, Arizona, United States, 85712
- Arizona Community Physicians
-
Tucson, Arizona, United States, 85741
- Orange Grove Family Practice
-
-
California
-
Anaheim, California, United States, 92801
- Anaheim Clinical Trials
-
Carlsbad, California, United States, 92008
- Radiant Research
-
Fresno, California, United States, 93726
- Research Center of Fresno, Inc.
-
Greenbrae, California, United States, 94904
- Marin Endocrine Care And Research, Inc.
-
Huntington Park, California, United States, 90255
- National Research Institute
-
Los Angeles, California, United States, 91402
- National Research Institute
-
Montclair, California, United States, 91710
- Catalina Research Institute
-
North Hollywood, California, United States, 91606
- Providence Clinical Research
-
Sacramento, California, United States, 95816
- Center for Clinical Trials of Sacramento, Inc.
-
-
Colorado
-
Aurora, Colorado, United States, 80045
- Denver VA Medical Center
-
Centennial, Colorado, United States, 75115
- Radiant Research
-
Colorado Springs, Colorado, United States, 80922
- Colorado Springs Health Partners - East
-
Littleton, Colorado, United States, 80128
- Columbine Family Practice
-
-
Florida
-
Crystal River, Florida, United States, 34429
- Nature Coast Clinical Reseaerch - Crystal River
-
Hialeah, Florida, United States, 33012
- Indago Research and Health Center, Inc.
-
Jacksonville, Florida, United States, 32256
- Clinical Neuroscience Solutions, Inc.
-
Miami, Florida, United States, 33173
- Research Institure of South Florida
-
Orlando, Florida, United States, 32801
- Clinical Neuroscience Solutions, Inc.
-
Palm Harbor, Florida, United States, 34684
- Palm Harbor Medical Associates
-
Pembroke Pines, Florida, United States, 33027
- South Broward Research
-
Pembroke Pines, Florida, United States, 33026
- Andres Patron, D.O., P.A
-
-
Georgia
-
Atlanta, Georgia, United States, 30331
- Atlanta Center for Medical Research
-
Atlanta, Georgia, United States, 30312
- Primary Care Research Group
-
-
Idaho
-
Meridian, Idaho, United States, 83646
- Solaris Clinical Research
-
-
Illinois
-
Chicago, Illinois, United States, 60604
- Michigan Avenue Internists
-
Skokie, Illinois, United States, 60077
- Medical and Procedural Specialists
-
Springfield, Illinois, United States, 62711
- HSHS Medical Group Diabetes Research
-
-
Indiana
-
Anderson, Indiana, United States, 46011
- Community Hospital of Anderson and Madison County, Inc.
-
Evansville, Indiana, United States, 47225
- Clinical Research Advantage
-
Franklin, Indiana, United States, 46131
- American Health Network of Indiana, LLC
-
New Albany, Indiana, United States, 47150
- American Health Network of Indiana, LLC
-
-
Kansas
-
Augusta, Kansas, United States, 67010
- Heartland Research Associates, LLC
-
Overland Park, Kansas, United States, 66210
- Overland Park Surgical Specialists, LLL dba College Park Family Care Center
-
Topeka, Kansas, United States, 66606
- Cotton O'Neil Clinical Research Center
-
Wichita, Kansas, United States, 67205
- Heartland Research Associates, LLC
-
Wichita, Kansas, United States, 67207
- Heartland Research Associates, LLC
-
-
Louisiana
-
Baton Rouge, Louisiana, United States, 70808
- Pennington Biomedical Research Center
-
-
Maine
-
Auburn, Maine, United States, 04210
- Maine Research Associates
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02215
- Joslin Diabetes Center
-
-
Minnesota
-
Edina, Minnesota, United States, 55435
- Radiant Research, Inc.
-
-
Missouri
-
Belton, Missouri, United States, 64012
- Ehrhardt Clinical Research, LLC
-
Hazelwood, Missouri, United States, 63042
- Healthcare Research Network
-
-
Montana
-
Butte, Montana, United States, 59701
- Mercury Street Medical Group
-
-
Nebraska
-
Elkhorn, Nebraska, United States, 68022
- Skyline Medical Center
-
-
Nevada
-
Henderson, Nevada, United States, 89047
- Nevada Family Care
-
Las Vegas, Nevada, United States, 89148
- Palm Research Center, Inc.
-
-
New York
-
Albany, New York, United States, 12208
- Albany Medical College
-
Laurelton, New York, United States, 11413
- Scott Research Center
-
-
North Carolina
-
Charlotte, North Carolina, United States, 28207
- American Health Research
-
Greensboro, North Carolina, United States, 27408
- Medication Management, LLC
-
Morehead City, North Carolina, United States, 28557
- Down East Medical Associates, PA
-
Wilmington, North Carolina, United States, 28401
- PMG Research of Wilmington, LLC
-
-
Ohio
-
Akron, Ohio, United States, 44311
- Radiant Research
-
Cincinnati, Ohio, United States, 45236
- Sentral Clinical Research Services, LLC
-
Columbus, Ohio, United States, 43213
- Canyon Medical Center, LLC
-
Columbus, Ohio, United States, 43231
- Aventiv Research
-
Franklin, Ohio, United States, 45005
- Prestige Clinical Research
-
Kettering, Ohio, United States, 45429
- Wells Institute for Health Awareness
-
Toledo, Ohio, United States, 43614
- University of Toledo
-
-
Oklahoma
-
Midwest City, Oklahoma, United States, 73110
- Oklahoma City Clinic - Midwest City
-
Norman, Oklahoma, United States, 73069
- Intend Research
-
Oklahoma City, Oklahoma, United States, 73112
- Lynn Health Science Institute
-
Oklahoma City, Oklahoma, United States, 73104
- Oklahoma City Clinic - Central
-
-
Oregon
-
Medford, Oregon, United States, 97504
- Clinical Research Institute of Southern Oregon, PC
-
-
Pennsylvania
-
Harleysville, Pennsylvania, United States, 19438
- Harleysville Medical Associates
-
Philadelphia, Pennsylvania, United States, 19107
- Thomas Jefferson University Hospital
-
Pittsburgh, Pennsylvania, United States, 15243
- Preferred Primary Care Phys Inc
-
Uniontown, Pennsylvania, United States, 15401
- Preferred Primary Care Physicians
-
-
South Carolina
-
Rock Hill, South Carolina, United States, 29732
- Clinical Research of Rock Hill
-
Spartanburg, South Carolina, United States, 29303
- Spartanburg Medical Research
-
-
Tennessee
-
Kingsport, Tennessee, United States, 37660
- Holston Medical Group, P.C.
-
Memphis, Tennessee, United States, 38119
- Clinical Neuroscience Solutions, Inc.
-
-
Texas
-
Austin, Texas, United States, 78758
- DCT-AACT, LLC dba Discovery Clinical Trials
-
Dallas, Texas, United States, 75230
- Dallas Diabetes and Endocrine Center
-
Dallas, Texas, United States, 75231
- Research Institute Of Dallas
-
DeSoto, Texas, United States, 75115
- Global Medical Research
-
Houston, Texas, United States, 77004
- Juno Research
-
Houston, Texas, United States, 77093
- PCP for Life - -Tidwell
-
Kerrville, Texas, United States, 78028
- Sante Clinical Research
-
San Angelo, Texas, United States, 78228
- Health Texas Research Institute
-
San Antonio, Texas, United States, 78229
- Clinical Trials of Texas, Inc.
-
San Antonio, Texas, United States, 78228
- Panacea Clinical Research
-
San Antonio, Texas, United States, 78240
- MacGregor Medical Center
-
San Antonio, Texas, United States, 78230
- Victorium Clinical Research Ltd.
-
Victoria, Texas, United States, 77901
- Crossroads Clinical Research, LLC
-
-
Utah
-
Clinton, Utah, United States, 84015
- Ericksen Research and Development, LLC
-
Murray, Utah, United States, 84123
- Radiant Research
-
West Jordan, Utah, United States, 84088
- Advanced Clinical Research
-
-
Washington
-
Port Orchard, Washington, United States, 98366
- Sound Healthcare
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Diagnosis of T2D 3 months prior to the Screening Visit.
- Body mass index (BMI) between ≥25 to ≤45 kg/m2 at the Screening Visit.
- Glycosylated hemoglobin A1c (HbA1c) ≥7.5 and ≤10.5%. 5. 6. On a stable (3 months prior to the Screening Visit) treatment regimen of metformin monotherapy of ≥1500 mg/day).
Exclusion Criteria:
- History of type 1 diabetes.
- Prior participation in a clinical study involving ITCA 650.
- Treatment with any GLP-1 receptor agonist (eg, liraglutide, exenatide) within 6 months prior to Screening.
- History or evidence, within the last 6 months prior to the Screening Visit, of myocardial infarction, coronary revascularization (coronary artery bypass grafting or percutaneous coronary intervention), unstable angina, or cerebrovascular accident or stroke.
- History or evidence of acute or chronic pancreatitis.
- History of medullary thyroid cancer or a family or personal history of multiple endocrine neoplasia type 2.
- Treatment of medications that affect GI motility.
- History of hypersensitivity to exenatide, empagliflozin, or glimepiride or to one of its excipients.
- Women that are pregnant, lactating, or planning to become pregnant.
- Chronic (>10 consecutive days) treatment with systemic corticosteroids within 8 weeks prior to screening.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Experimental: Group 1
ITCA 650 20/60 mcg/day
|
ITCA 650 osmotic mini-pump delivering exenatide 20/60 mcg/day
|
EXPERIMENTAL: Experimental: Group 2
Empagliflozin 10 mg/day and 25 mg/day
|
10 mg/day and 25 mg/day
|
EXPERIMENTAL: Experimental: Group 3
Glimepiride 1-6 mg/day
|
1-6 mg/day
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Reduction in glycosylated hemoglobin A1c
Time Frame: Randomization to 69 weeks
|
To determine whether ITCA 650 is non-inferior either to empagliflozin or to glimepiride in reducing glycosylated hemoglobin A1c (HbA1c) in patients with T2D following 65 weeks of treatment and 4 weeks of post treatment follow up.
|
Randomization to 69 weeks
|
Reduction in weight
Time Frame: Randomization to 69 weeks
|
To determine whether ITCA 650 is non-inferior either to empagliflozin or to glimepiride in reducing weight in patients with T2D following 65 weeks of treatment and 4 weeks of post treatment follow up.
|
Randomization to 69 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
March 3, 2017
Primary Completion (ACTUAL)
January 26, 2018
Study Completion (ACTUAL)
January 26, 2018
Study Registration Dates
First Submitted
February 9, 2017
First Submitted That Met QC Criteria
February 17, 2017
First Posted (ACTUAL)
February 23, 2017
Study Record Updates
Last Update Posted (ACTUAL)
March 7, 2019
Last Update Submitted That Met QC Criteria
March 4, 2019
Last Verified
March 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Glucose Metabolism Disorders
- Metabolic Diseases
- Endocrine System Diseases
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Hypoglycemic Agents
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Anti-Arrhythmia Agents
- Immunosuppressive Agents
- Immunologic Factors
- Hormones
- Hormones, Hormone Substitutes, and Hormone Antagonists
- Anti-Obesity Agents
- Incretins
- Sodium-Glucose Transporter 2 Inhibitors
- Empagliflozin
- Glimepiride
- Exenatide
Other Study ID Numbers
- ITCA 650-CLP-203
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Yes
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus, Type 2
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Mannkind CorporationTerminatedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
Scripps Whittier Diabetes InstituteSan Diego State UniversityCompletedType 2 Diabetes Mellitus (T2DM)United States
-
RWTH Aachen UniversityBoehringer IngelheimCompletedDiabetes Mellitus Type 2 (T2DM)Germany
-
Griffin HospitalCalifornia Walnut CommissionCompletedDIABETES MELLITUS TYPE 2United States
-
US Department of Veterans AffairsAmerican Diabetes AssociationCompletedType 2 Diabetes MellitusUnited States
-
Dexa Medica GroupCompletedType-2 Diabetes MellitusIndonesia
-
University Hospital Inselspital, BerneCompletedType 2 Diabetes MellitusSwitzerland
-
India Diabetes Research Foundation & Dr. A. Ramachandran...CompletedTYpe 2 Diabetes MellitusIndia
-
AstraZenecaNot yet recruiting
Clinical Trials on ITCA 650 20/60 mcg/day
-
Intarcia TherapeuticsCompletedHealthy Adult Premenopausal Female VolunteersUnited States
-
Intarcia TherapeuticsCompletedDiabetes Mellitus, Type 2United States
-
Intarcia TherapeuticsWithdrawnType 2 DiabetesUnited States
-
Intarcia TherapeuticsWithdrawnType 2 DiabetesUnited States
-
Intarcia TherapeuticsCompletedType 2 DiabetesUnited States, Croatia, Latvia, Denmark, Germany
-
MedImmune LLCCompletedChronic Lymphocytic Leukemia | Non-Hodgkin LymphomaUnited States, Poland
-
University College DublinDepartment of Agriculture Food and the MarineCompletedVitamin D Deficiency | Aging WellIreland
-
Intarcia TherapeuticsWithdrawnType 2 DiabetesUnited States
-
Intarcia TherapeuticsCompleted
-
Fundación Santiago Dexeus FontRecruiting